The BCCM/IHEM Biomedical Fungi/Yeasts collection hosts 1200 Candida albicans strains of the Vanbreuseghem mycotheque isolated between 1951 and 1997. From this collection, 469 freeze-dried C. albicans strains, producing chlamydospores, germ tubes and forming green colonies on CHROMagar, all isolated before 1990, were screened to identify the Candida dubliniensis isolates. Screening was performed in different steps using the growth at 45 o C, the assimilation of xylose, the intracellular ß-glucosidase activity test and C. dubliniensis-speci c polymerase chain reaction (PCR) with primers from ACT1 intron sequence. Five isolates (1%) were identi ed as C. dubliniensis: one isolate was not documented, the others were of oropharyngeal origin of which two (1987 and 1990) were from proven human immunodeciency virus patients.
Introduction
Candida dubliniensis is a recently described yeast species principally associated with carriage and disease in the oral cavities of human immunode ciency virus (HIV)-infected individuals. This species shows phenotypic characteristics that have long been considered speci c for Candida albicans, that is the production of germ tubes and chlamydospores. This close similarity has hindered differentiation between the two species in clinical laboratories [1] .
Since 1995, advances in phenotypic and genotypic methods for yeast identi cation have helped de ne differences between C. albicans and C. dubliniensis. Whereas C. albicans colonies are light bluegreen in colour on CHROMagar (CHROMagar Microbiology, Paris, France), C. dubliniensis colonies are a much darker green colour. Yet, this characteristic can be lost following subculture and storage [2] .
Comparative growth analysis at high temperatures, such as 45 o C, has also been suggested as a means of discriminating C. dubliniensis from C. albicans [3] .
Nevertheless, the absence of growth at 45 o C should only be used as a con rmatory test or in conjunction with one or more other identi cation tests as some C. albicans strains also do not grow at this temperature [4] . The second test could be the xylose assimilation test as it is known that C. dubliniensis, unlike the great majority of C. albicans isolates, is unable to assimilate xylose after a short incubation of 48 h [1] .
In an original study by Boerlin et al. [5] it was observed that, in contrast to C. albicans, C. dubliniensis isolates did not appear to produce ß-glucosidase activity. Nevertheless, it was later demonstrated that 12.5% of C. albicans isolates were ß-glucosidase negative [6] .
Finally, various molecular methods exist to con rm the C. dubliniensis identi cation, for example, restriction fragment length polymorphism (RFLP) hybridization with C. albicans probe (27A or Ca3), karyotype analysis, random ampli ed polymorphic DNA (RAPD), internal transcribed spacer (ITS) sequencing or PCR with primers speci c of C. dubliniensis. The last was applied to our isolates [7] .
Material and methods
The Vanbreuseghem mycotheque is made up of 12,500 fungi kept under freeze-drying. It includes, among others, around 1200 C. albicans isolates collected during The yeasts had been stored under freeze-drying since the early 1950s. The isolates had originally been identi ed phenotypically as C. albicans on the basis of the presence of chlamydospores on Rice Cream medium. Among the 469 yeasts, 4 (1%) were originally isolated in the 1950s, 9 (2%) in the 1960s, 150 (32%) in the 1970s and 306 (65%) in the 1980s up to 1990. The majority of the yeasts were isolated in European countries (66%), with those from Belgium being particularly heavily represented (62%). Nevertheless, 147 isolates (31%) came from Rwanda and were mostly from suspected AIDS patients. AIDS had been con rmed in only 70 of those patients. Fifteen of the specimens came from other diverse non-European geographical areas. Among the 469 yeasts, 450 were of human origin: 115 from either the oral cavity or sputum (24%), 42 from faeces, 32 from skin/nail, 29 from vagina, 7 from deep organs and 25 from other clinical settings. The origin of the other 200 isolates (42%) is unknown but they are probably mostly of human origin.
The identi cation methods chosen for a rst screening were growth at 45 o C [3] , used in conjunction with the xylose assimilation test performed according to Barnett et al. [9] . The second screening relied on the inability of C. dubliniensis to produce intracellular ß-glucosidase activity. This test was performed according to Boerlin et al. [5] .
The nal con rmation was a genotypic characterization carried out using PCR. Two sets of primers were used: the universal fungal primers (RNAR and RNAF), which generate a 610 bp fragment for both species, and the species-speci c primers from the ACT1 intron sequence of C. dubliniensis (DUBR and DUBF), which generate a 288 bp speci c fragment [7] .
Results
The results of the screening are presented in Table 1 , 464 (99%) of the isolates were C. albicans, whereas ve isolates (1%) were newly de ned as C. dubliniensis. Four of these were isolated in Belgium at the Institute of Tropical Medicine in Antwerp. The two oldest strains were isolated respectively in 1974 and 1977, both from sputum, the rst from a Belgian patient and the second from a Syrian patient. No underlying disease was recorded for the rst, the second had a lesion mimicking facial actinomycosis. The three other strains were isolated in 1987, 1988 and 1990. The isolates from 1987 and 1990 were both from mouthwashings from Belgian AIDS patients, whereas the last was isolated from an 
unknown human source in Amsterdam (The Netherlands).
Discussion
Most isolates of C. dubliniensis have been recovered from cases of oral candidiasis in HIV-infected patients [9] . The results are in agreement with this observation as the four well-documented isolates are from this setting with two isolates from AIDS patients. Whereas some studies [10, 11] have shown that C. dubliniensis isolates dating back to the 1950s existed, no isolate collected before 1970 could be found in the Vanbreuseghem mycotheque, probably as a consequence of the small number of such isolates (nˆ13).
Regarding the geographical distribution of the isolates, we were unable to nd any C. dubliniensis among our 147 Rwandan isolates. To date, no African isolate of C. dubliniensis has ever been reported. In contrast, one Syrian isolate can be added to the recently isolated Israeli strains [12] , con rming that this species is present in the Middle East. Compared with the percentage of C. dubliniensis obtained by Odds et al. [6] in the archival stock of the Janssen Research Foundation (around 2%), the percentage of C. dubliniensis obtained in this study is very low (around 1%). However, the majority of the 2589 isolates studied by Odds et al. are of European origin (80.7%) or from North America (3.5%) and if the African isolates are excluded from our collection, taking only the European isolates into account, then we reach a percentage of 1.5%, which is rather similar.
